ABSTRACT
This study aimed to identify the cause of azoospermia in a 38-year-old infertile man who was referred for genetic testing. Cytogenetic evaluation was performed by G-banding, C-banding, and FISH using centromeric probes for chromosomes X and Y and showed the presence of a monocentric isochromosome Y with a complex, mosaic karyotype 45,X/46,X,i(Y)(q10)/46,XX/47,XX,i(Y)(q10). Multiplex PCR for the commonly deleted genes in the AZFa, AZFb, and AZFc regions of the Y chromosome was performed and indicated the presence of all 3 regions. Further, PCR amplification followed by DNA sequencing of the SRY gene was done, which ruled out mutations in that gene. To identify the position of the SRY gene, FISH using a locus-specific probe was used and showed that the gene had been translocated to chromosome 3. Subtelomere FISH for 3q and Yp evidenced that the subtelomeric region of the Y chromosome was found on the terminal region of 3q. The clinical symptoms of the patient can be attributed to this abnormal genotype. The importance of genetic testing in infertile patients and the need for genetic counselling to prevent the transmission of the defect are emphasized.
Subject(s)
Azoospermia/genetics , Chromosomes, Human, Pair 3 , Genes, sry , Karyotyping , Sex Chromosome Aberrations , Sex-Determining Region Y Protein/genetics , Adult , Cell Line , Chromosome Banding , Chromosomes, Human, Y , Humans , In Situ Hybridization, Fluorescence , Male , Multiplex Polymerase Chain ReactionABSTRACT
Osteosarcoma (OSA) is the most frequently occurring malignant primary bone tumour in dogs and children and arises from cells of the osteoblast lineage. Inappropriate Wnt signalling activity has been implicated in human OSA. Altered expression of ß-catenin, an integral member of the Wnt signalling pathway, has been associated with numerous human cancers, including OSA. In this study, 30 of the 37 primary canine OSA tissues and 2 of the 3 metastatic OSAs were positive for ß-catenin expression as determined by immunohistochemistry, whereas 2 normal bones stained negative for ß-catenin. No mutations were identified in exon 3 of ß-catenin in the three OSA cases in which DNA sequencing was performed. Finally, there was no relationship between ß-catenin expression and overall survival time or disease-free interval. Our results indicate ß-catenin is frequently expressed within the cytoplasm of neoplastic cells in canine OSA but contains no detectable mutations in exon 3, similar to human OSA.